MedTrace Logo

Kaiser Permanente HIV Cohort Study

NCT01339403 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 282368

Last updated 2015-04-03

Study results available
· View outcomes & findings →

Summary

Human Immunodeficiency Virus (HIV) infected patients in the Kaiser Permanente HIV registry wil be followed in the usual clinical care to estimate the rates of specified clinical events. The rates will be stratified by relevant characteristics like age, CD4 counts, HIV Viral Load (VL), HIV medication history. The rates in the HIV infected cohort wil be compared with the rates of these events in patients in the Kaiser Permanente database who are not infected with HIV.

Conditions

Interventions

OTHER

non-interventional trial

No study specific intervention, non-interventional trial

OTHER

non-interventional trial

No study specific intervention, non-interventional trial

Sponsors & Collaborators

  • Kaiser Permanente

    collaborator OTHER

  • Pfizer

    collaborator INDUSTRY

  • ViiV Healthcare

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2013-10-31
Completion
2013-10-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01339403 on ClinicalTrials.gov